You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
寶萊特(300246.SZ):為開拓血液淨化市場 擬與智立醫學共設四川寶萊特智立醫療科技
格隆匯 04-19 17:23

格隆匯 4 月 19日丨寶萊特(300246.SZ)公佈,公司,基於戰略規劃和經營發展需要,為開拓血液淨化市場,公司擬與北京智立醫學技術股份有限公司(“智立醫學”)共同出資設立控股子公司四川寶萊特智立醫療科技有限公司(暫定名,最終以登記機關核准的名稱為準,合資公司),註冊資本1800萬元人民幣。其中:公司出資1170萬元人民幣,佔合資公司註冊資本的65%智立醫學出資630萬元人民幣,佔合資公司註冊資本的35%

北京智立醫學技術股份有限公司是一家致力於與腎臟健康相關的醫學研究和產品研發、銷售和服務,醫療機構與項目投資,為患者、醫院客户提供一體化解決方案的醫療器械經營為主的企業

與智立醫學設立合資公司將進一步完善全國佈局,更大程度發現有渠道與銷售網絡優勢、規模優勢和協同作用,投資雙方可以發揮各自在資本、技術、管理、市場方面的優勢,有助於為公司未來業績增長帶來新的驅動力,提升公司的綜合競爭能力,符合公司的發展戰略與全體股東利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account